Kovack Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Kovack Advisors’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5	Closed	-$1K	–	711
2020 Q4	$1K	Buy	+5	New	+$45	﹤0.01%	614

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kovack Advisors's DBD Position: Q2 2023 in Review

Kovack Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 24,086 shares — an estimated $28.9K sold.

Kovack Advisors first reported a position in DBD in Q1 2015 and held it in 33 quarters. The position peaked at $1.13M in Q2 2016. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

Kovack Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
Kovack Advisors sold 24,086 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $28.9K.
Kovack Advisors first reported a position in Diebold Nixdorf Incorporated in Q1 2015 and held it in 33 quarters.
Kovack Advisors's Diebold Nixdorf Incorporated position peaked at $1.13M in Q2 2016.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Kovack Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.